Droxidopa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Novadoz Pharmaceuticals Llc. The primary component is Droxidopa.
| Product ID | 72205-074_381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d |
| NDC | 72205-074 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Droxidopa |
| Generic Name | Droxidopa |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-02-19 |
| Marketing Category | ANDA / |
| Application Number | ANDA211741 |
| Labeler Name | Novadoz Pharmaceuticals LLC |
| Substance Name | DROXIDOPA |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Catecholamines [CS],Increased Blood Pressure [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-02-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0532 | Droxidopa | Droxidopa |
| 0054-0533 | Droxidopa | Droxidopa |
| 0054-0534 | Droxidopa | Droxidopa |
| 0832-0720 | Droxidopa | Droxidopa |
| 0832-0721 | Droxidopa | Droxidopa |
| 0832-0722 | Droxidopa | Droxidopa |
| 27241-199 | Droxidopa | Droxidopa |
| 27241-200 | Droxidopa | Droxidopa |
| 27241-201 | Droxidopa | Droxidopa |
| 27808-199 | droxidopa | droxidopa |
| 27808-200 | droxidopa | droxidopa |
| 27808-201 | droxidopa | droxidopa |
| 31722-010 | Droxidopa | Droxidopa |
| 31722-014 | Droxidopa | Droxidopa |
| 31722-015 | Droxidopa | Droxidopa |
| 50228-429 | Droxidopa | droxidopa |
| 50228-430 | Droxidopa | droxidopa |
| 50228-431 | Droxidopa | droxidopa |
| 59651-375 | Droxidopa | Droxidopa |
| 59651-376 | Droxidopa | Droxidopa |
| 59651-377 | Droxidopa | Droxidopa |
| 63304-086 | droxidopa | droxidopa |
| 63304-104 | droxidopa | droxidopa |
| 63304-112 | droxidopa | droxidopa |
| 67386-820 | Northera | droxidopa |
| 67386-821 | Northera | droxidopa |
| 67386-822 | Northera | droxidopa |